Thrombosis Drugs Market to Reach US$ 54.63 Billion by 2031 Driven by Rising Cardiovascular Disease Burden
The global thrombosis drugs market is witnessing strong growth due to the increasing prevalence of cardiovascular disorders, deep vein thrombosis, pulmonary embolism, and atrial fibrillation worldwide. Technological advancements in anticoagulant therapies, coupled with growing awareness regarding thrombotic disorders, are significantly contributing to market expansion. Pharmaceutical companies...
0 Kommentare
0 Anteile
46 Ansichten
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt